Member Info for HarChris

I am saying it's not the job of the new CEO to immediately correct the share price, that cannot be his main priority on day one.

I sold earlier in the year for that exact reason, I didn't believe Graham cared about the fate of shareholders in the short term and thus the chance of it falling further was high and too much of a risk for me. I am now comforted that this will change and continue to buy at this price because I believe that the share price will in the not too distant future be much higher.

If in the meantime it goes lower because DA has been in the job for two weeks and is probably setting out a plan then so be it, I understand that and accept it.

We are down here because there is no forward plan, there is now no trust from the market that novacyt will succeed post covid. Do you really think putting out rns after rns about new products which haven't made any money yet' is going to halt the slide? Do you think if they put out a Q3 update today stating the figures we all were expecting it would halt the slide? I dont.

It's going to take wholesale strategic changes to turn this around not just a sudden flurry of communication.

And no I wouldn't be bothered about £2 if it based on nothing but a few more weeks of silence, this is AIM and I'm used to wild, wild swings in the share price.

I would if months passed but I do not like the idea of having a new CEO in charge that is dictated to by the market to such a degree that he has to keep putting out news to halt a short term slide.

Well personally I believe that no business really cares about shareholders in the same way that no shareholders really care about a business, they both use each other for personal gain (one to support the company and be there to raise funds when necessary and the other to receive a return for that support).

As it happens I don't see what novacyt could do over night now to boost the share price substantially (besides a share buyback) but there's a lot that can be done over the next 6-12 months - so really as someone who is buying at this low price I am trusting that they understand this now and are capable of turning things around going forward... that does not mean a higher share price tomorrow or even next month but progress towards that once the new CEO has settled in.

Mainly CO because the CEO was changing hands and in the end of the day that's where the buck stops. I thought it would make sense to at least give the new boss some time to make wholesale changes rather than put him immediately on the back foot.

I still don't get why anyone is bothered about a move from 250p to 238p this week unless you are itching to sell and be done with ncyt - and if you are then that's all good and well but DA is not going to accommodate you...

I think someone already asked this and the response was a) no Q3 update (same as last year) and b) full year trading update end of Jan (like last year).

Shouldn't be too much of a surprise though - ~£97m rev

This is a niche small cap company in the healthcare sector not a country going to war - we don't need a strong charismatic leader, we need a competent business executive that is able to navigate the transition from covid test provider into leading international diagnostics business and is skilled in attracting institutional investors.

And if it doesn't fall much today let's not forget it fell about 7% yesterday in anticipation of this delayed rns...

Crl we can't assume that we would be making the same £100m in 2022, revenue will need to come from new non covid avenues and acquisitions to maintain/grow from here. So in reality a) these tests will probably be approved by the start of next year and b) some of that £18m was expected to drop off anyway...

Today I did the same, I added substantially near the end of the day but I'm fully aware it's going to take some time to turn this around and rebuild investor interest again and there's every chance it gets even worse before it gets better.

I think it's worth the risk for the reasons Bluelight gave @16:35 but there's no doubt it this has been a miserable period, especially for those with very high averages that may never see a return to profit. GL to all those still standing.

Not claiming it to mean anything but still amazing to think the share price briefly reached where we are today with £1m in cash, £6m debt and just a handful of sales three weeks before the WHO declared covid a pandemic.

*taken from a tweet from Larry on twitter*

On Feb 17th the share price spiked to 223p (today closed 239p). On this day their first CE marked coronavirus test was launched and this was what the rns stated:
'Primerdesign has already received requests for quotations for 288,000 CE-Mark tests since they were made available to pre-order on 14 February 2020. The Company has received orders for 40,000 RUO tests and requests for quotations for an additional 35,000 RUO tests prior to the launch of the COVID-19 clinical version. Demand for the tests has come from China, the US and the UK, as well as many other countries around the world.'

The world was still in denial about the pandemic and we were about 5 weeks away from our first lockdown. I know it means very little and it took another six weeks til that high was smashed but still find this fact staggering.

I've got to admit I think today is the beginning of the end for mass testing in the UK, the government have felt for ages that all this money for testing is actually having a negative effect on the country (others seeing us as a place to avoid as we have higher case numbers).

It is not a big concern for me though, this had to happen at some point and the market cap of the company reflects this already. Plus it seems our revenue is spread out across geographies so we we should continue to bring in meaningful revenue from testing in 2022 at the minimum.

It's another dent sentiment-wise though frustrating - that tide turning is a little further away once again!

Can we all acknowledge the kindness that Dunc has been showing us over the past few weeks. He only appears when the share price is in the doldrums because he is concerned PIs won't sell and then it goes lower and they regret it. He was kind enough to warn us all about the enormous placing two weeks ago as well as the huge buyback of shares last week.

Keep up the altruistic work my friend, there aren't enough selfless individuals like you.

@dunc well of course, if not we'd be sitting at a minimum of £10 a share if we expected £40m EBITDA covid revenue ad infinitum.

Covid revenue will (likely) half yoy and the focus will grow ever more on non covid sales avenues.

Same reason as we didn't get Q3 figures in 2020? or 2019? or 2018? etc etc

The dump you speak of is currently 1%, hardly plummeting is it?

Hope this turns around for you too shelldonald and aren't suffering too much yourself xox

Oh wait you are invested right? I can't seem to tell as sometimes you are, sometimes you are ridiculing the rest of us for investing here! It changes by the day.

My average is low my dear friend donald and I'm happy to take the risk and buy more if this gets marked down this week.
Nothing to be worried about as far as i'm concerned, would prefer all this out the way first before DA turns the ship around.

Not only have we had a change in CEO it also now appears that Graham's exit was somewhat forced. You could therefore argue there's been a vacuum at the top for a good month or so which would explain the lack of news and updates.

All we know from the silence is that we've not won a major contract in the past month but besides that it does not infer that there's nothing positive behind the scenes - your claims are pretty shameful and nothing but pure speculation.